CHLORZOXAZONE
- Product NDC
- 59651-307
- 11-digit product format
- 596510307
- Labeler code
- 59651
- Product ID
- 59651-307_13956b60-a22d-4ee8-af95-460830ebfbc9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CHLORZOXAZONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA089853
- Marketing category
- ANDA
- Marketing start
- 2023-08-17
- Substance
- CHLORZOXAZONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CHLORZOXAZONE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLORZOXAZONE | 750 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | H0DE420U8G |
| Rxcui | 197502, 1088934, 1088936 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-307-01 | CHLORZOXAZONE | 100 in 1 BOTTLE | TABLET | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-307 | CHLORZOXAZONE TABLET [AUROBINDO PHARMA LIMITED] | 4 | Current NDC, 1 package rows | 20231118_52d3aa2c-f88f-4de7-b5ae-df8a46e94879.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-307-01 | 59651030701 | 100 TABLET in 1 BOTTLE (59651-307-01) | 100 tablet | 2023-08-17 | No | No | Current |
| 59651-307-71 | 59651030771 | 7000 TABLET in 1 BAG (59651-307-71) | 7000 tablet | 17-AUG-23 | | | Current |